Serina Therapeutics, INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

AMEX
Serina Therapeutics files an amendment to its Form S-1 registration statement, covering the issuance and resale of common stock and warrants following its merger with AgeX Therapeutics.
AMEX
Serina Therapeutics aims to raise capital through warrant exercises while registering shares for resale, following a merger and name change from AgeX Therapeutics.
AMEX
Serina Therapeutics files for an offering of common stock and warrants to support its neurological disease and pain treatment programs.